Industry: Drug Manufacturing, Pharmaceuticals, Biotechnology
Founded in 1997 as RedCell Inc., ConjuChem Biotechnologies Inc. (“ConjuChem” or the “Company”) is a publicly traded Canadian biotechnology company dedicated to the discovery of novel therapeutics with an initial focus on diabetes. ConjuChem is currently managing several research programs in-house and has one product in clinical development. We are focused on discovering and developing new drugs based on our novel technology platforms called Drug Affinity Complex (DACÔ) and Preformed Conjugate-Drug Affinity Complex (PC-DACÔ). When applied to a compound, DACÔ or PC-DACÔ can create a new drug with similar therapeutic activity but a significantly longer duration of activity in the ( www.conjuchem.com )
ConjuChem Inc.
225 Avenue President Kennedy
Montréal, Quebec H3X 3Y8
Canada
Tel: (514) 844-5558
Fax: (514) 844-1119